Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
ATLANTA, June 02, 2016 (GLOBE NEWSWIRE) -- Alimera Sciences (NASDAQ:ALIM), a leader in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today...
-
Despite other prior treatments, improvements in visual acuity and retinal thickness were seen in the majority of patients Efficacy and safety data are comparable with Phase III FAME clinical trials...
-
ATLANTA, May 17, 2016 (GLOBE NEWSWIRE) -- Alimera Sciences (NASDAQ:ALIM), a leader in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced...
-
ATLANTA, May 11, 2016 (GLOBE NEWSWIRE) -- Alimera Sciences, Inc. (NASDAQ:ALIM) (Alimera), a leader in research, development and commercialization of prescription ophthalmic pharmaceuticals, today...
-
First quarter revenue improved 49% compared to first quarter 2015 due to increasing ILUVIEN® sales in the U.S.Record benefit investigations in the first quarter indicate increasing physician...
-
ATLANTA, April 26, 2016 (GLOBE NEWSWIRE) -- Alimera Sciences (NASDAQ:ALIM), a leader in research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced that...
-
Annual revenue increased 167% for 2015 compared to 2014Record fourth quarter 2015 revenue increased 241% over fourth quarter 2014Company to host conference call on March 3, 2016 at 10:00 AM ET ...
-
ATLANTA, Feb. 29, 2016 (GLOBE NEWSWIRE) -- Alimera Sciences (NASDAQ:ALIM), a leader in the research, development and commercialization of prescription ophthalmic pharmaceuticals, today announced...
-
ALPHARETTA, Ga., Feb. 18, 2016 (GLOBE NEWSWIRE) -- Alimera Sciences (NASDAQ:ALIM), a leader in research, development and commercialization of prescription ophthalmic pharmaceuticals, today...
-
Company Expects to Begin Generating Revenue in the First Quarter of 2013 Alimera Will Host a Conference Call at 4:30 P.M. ET Today ATLANTA, Aug. 9, 2012 (GLOBE NEWSWIRE) -- Alimera Sciences,...